Key result
Current genetic and epigenetic approaches have failed to deliver expected clear-cut and reliable information for clinical decision-making in patients with myocardial infarction.
Population
Patients with myocardial infarction (MI) and coronary artery disease
Design
Review
Authors
Loading...
Genetic/epigenetic markers should not guide MI decisions yet; leaves open need for validated, clinically actionable tools.
Despite extensive research, genetic and epigenetic markers for myocardial infarction are not yet reliable enough for routine clinical decision-making.
Stojan Kariž (2012) conducted a review in Myocardial Infarction. Genetic and epigenetic markers was evaluated. Current genetic and epigenetic approaches have failed to deliver expected clear-cut and reliable information for clinical decision-making in patients with myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: